SE8004792L - Nya tetra- eller pentapeptider, forfaranden for framstellning av desamma och farmaceutiska kompositioner innehallande desamma - Google Patents

Nya tetra- eller pentapeptider, forfaranden for framstellning av desamma och farmaceutiska kompositioner innehallande desamma

Info

Publication number
SE8004792L
SE8004792L SE8004792A SE8004792A SE8004792L SE 8004792 L SE8004792 L SE 8004792L SE 8004792 A SE8004792 A SE 8004792A SE 8004792 A SE8004792 A SE 8004792A SE 8004792 L SE8004792 L SE 8004792L
Authority
SE
Sweden
Prior art keywords
moiety
optionally substituted
nitrophenyl
phenyl
carbon atoms
Prior art date
Application number
SE8004792A
Other languages
Unknown language ( )
English (en)
Other versions
SE448302B (sv
Inventor
J Bouchaudo
D Farge
C James
Original Assignee
Rhone Poulenc Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Ind filed Critical Rhone Poulenc Ind
Publication of SE8004792L publication Critical patent/SE8004792L/sv
Publication of SE448302B publication Critical patent/SE448302B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8004792A 1979-06-29 1980-06-27 Tetra- eller pentapeptider och faramceutiska kompositioner innehallande desamma SE448302B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7916845A FR2460290A1 (fr) 1979-06-29 1979-06-29 Nouveaux tetra- ou pentapeptides, leur preparation et les medicaments qui les contiennent

Publications (2)

Publication Number Publication Date
SE8004792L true SE8004792L (sv) 1980-12-30
SE448302B SE448302B (sv) 1987-02-09

Family

ID=9227279

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8004792A SE448302B (sv) 1979-06-29 1980-06-27 Tetra- eller pentapeptider och faramceutiska kompositioner innehallande desamma

Country Status (16)

Country Link
US (1) US4742048A (sv)
JP (1) JPS5636440A (sv)
AU (1) AU544863B2 (sv)
BE (1) BE884077A (sv)
CH (1) CH651577A5 (sv)
DE (1) DE3024281A1 (sv)
DK (1) DK154940C (sv)
FR (1) FR2460290A1 (sv)
GB (1) GB2053231B (sv)
IE (1) IE51058B1 (sv)
IT (1) IT1131395B (sv)
LU (1) LU82567A1 (sv)
NL (1) NL8003762A (sv)
NZ (1) NZ194179A (sv)
SE (1) SE448302B (sv)
ZA (1) ZA803887B (sv)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539155A (en) * 1978-11-14 1985-09-03 Fuisawa Pharmaceutical Company, Ltd. New peptide, process for preparation thereof and use thereof
US4749691A (en) * 1978-11-14 1988-06-07 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
US4725582A (en) * 1978-11-14 1988-02-16 Fujisawa Pharmaceutical Company, Ltd. Peptide, process for preparation thereof and use thereof
US4458078A (en) * 1978-11-14 1984-07-03 Fujisawa Pharmaceutical Company, Ltd. Oxazole derivatives
US4801580A (en) * 1978-11-14 1989-01-31 Fujisawa Pharmaceutical Company, Ltd. Peptide, process for preparation thereof and use thereof
US4354966A (en) 1978-11-14 1982-10-19 Fujisawa Pharmaceutical Co., Ltd. Peptides, process for preparation thereof and use thereof
DK156252C (da) * 1979-07-31 1989-12-18 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf
JPS5645449A (en) * 1979-07-31 1981-04-25 Fujisawa Pharmaceut Co Ltd Novel peptide, its pharmaceutically acceptable salt and preparation of the same
EP0027260B1 (en) * 1979-10-11 1985-03-13 Fujisawa Pharmaceutical Co., Ltd. Peptides, processes for their preparation and pharmaceutical compositions containing them
JPS57114556A (en) * 1980-10-27 1982-07-16 Fujisawa Pharmaceut Co Ltd Novel peptide compound and its preparation
IE51684B1 (en) * 1980-10-27 1987-02-04 Fujisawa Pharmaceutical Co Peptides,process for their preparation and pharmaceutical compositions containing them
DK465681A (da) * 1980-11-11 1982-05-12 Fujisawa Pharmacetical Co Ltd Fremgangsmaade til fremstilling af peptidderivater
US4497729A (en) * 1980-12-01 1985-02-05 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
GR81332B (sv) * 1980-12-01 1984-12-11 Fujisawa Pharmaceutical Co
FR2496654A1 (fr) * 1980-12-19 1982-06-25 Rhone Poulenc Sante Nouveaux tri-, tetra- et pentapeptides, leur preparation et les medicaments qui les contiennent
US4493794A (en) * 1980-12-31 1985-01-15 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
GR77929B (sv) 1981-01-29 1984-09-25 Fujisawa Pharmaceutical Co
GR79114B (sv) * 1981-01-29 1984-10-02 Fujisawa Pharmaceutical Co
US4399066A (en) 1981-01-29 1983-08-16 Fujisawa Pharmaceutical Co., Ltd. Novel peptide, process for preparation thereof and use thereof
JPH068312B2 (ja) * 1981-01-29 1994-02-02 藤沢薬品工業株式会社 新規ペプチドの製造法
US4504471A (en) * 1982-09-27 1985-03-12 Fujisawa Pharmaceutical Co., Ltd. Animal growth promotant and method of use for animal growth
DE3485094D1 (de) * 1983-01-25 1991-10-31 Ciba Geigy Ag Neue peptidderivate.
NZ229004A (en) * 1988-05-19 1993-09-27 Immunobiology Res Inst Inc Tetrapeptides having t cell helper acitivity
KR900701298A (ko) * 1988-09-30 1990-12-01 원본미기재 T-세포 억제작용을 보유한 펩티드
US5036050A (en) * 1989-01-12 1991-07-30 Immunobiology Research Institute, Inc. Compositions containing thymopentin for topical treatment of skin disorders
US6048531A (en) * 1991-04-15 2000-04-11 Albany Medical College Immunogenic composites capable of stimulating production of anti-peptide antibodies, pharmaceutical compositions employing these composites and methods of selectively inducing production of anti-peptide antibodies
US5312831A (en) * 1993-05-12 1994-05-17 American Cyanamid Company Urethanes and ureas that induce cytokine production
JPH08510258A (ja) * 1993-05-14 1996-10-29 マリンクロット・メディカル・インコーポレイテッド ペプチド内へ導入するための配位子前駆体
AUPO161196A0 (en) * 1996-08-13 1996-09-05 Commonwealth Scientific And Industrial Research Organisation Novel compounds
EP0922958B1 (de) * 1997-12-11 2002-10-02 Roche Diagnostics GmbH Entstörung von diagnostischen Verfahren durch Peptide aus D-Aminosäuren
WO2001046127A1 (fr) * 1999-12-22 2001-06-28 Om Pharma Pseudodipeptides acyles porteurs d'un bras auxiliaire fonctionnalise
EP3323424A1 (en) 2016-11-17 2018-05-23 Cyanimal IP Cyaa polypeptides as immune enhancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2033906B (en) * 1978-10-19 1982-12-01 Anvar Water-soluble compounds derived from extracts of streptomyces stimulosus process for their production and compositions containing them
FR2442889A1 (fr) * 1978-10-19 1980-06-27 Anvar Nouveaux composes hydrosolubles provenant d'extraits de streptomyces stimulosus, leur obtention, leur application a titre d'adjuvants immunologiques et compositions les contenant
DE2963446D1 (en) * 1978-11-14 1982-09-16 Fujisawa Pharmaceutical Co New lactyl tetrapeptide, processes for preparation thereof and pharmaceutical compositions containing it
US4311640A (en) * 1978-11-14 1982-01-19 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
EP0013856B1 (en) * 1978-12-22 1983-03-09 ANVAR Agence Nationale de Valorisation de la Recherche New compounds associating peptidyl or aminoacyl residues to lipophilic groups and pharmaceutical compositions containing said new compounds

Also Published As

Publication number Publication date
ZA803887B (en) 1981-07-29
NL8003762A (nl) 1980-12-31
DK154940C (da) 1989-05-29
IT8023072A0 (it) 1980-06-26
NZ194179A (en) 1983-11-18
FR2460290B1 (sv) 1983-12-16
IE801342L (en) 1980-12-29
FR2460290A1 (fr) 1981-01-23
GB2053231A (en) 1981-02-04
US4742048A (en) 1988-05-03
JPS5636440A (en) 1981-04-09
AU544863B2 (en) 1985-06-20
JPH0159276B2 (sv) 1989-12-15
IE51058B1 (en) 1986-09-17
CH651577A5 (fr) 1985-09-30
LU82567A1 (fr) 1981-02-03
GB2053231B (en) 1983-09-07
BE884077A (fr) 1980-12-29
DK277780A (da) 1980-12-30
DK154940B (da) 1989-01-09
DE3024281A1 (de) 1981-01-08
SE448302B (sv) 1987-02-09
IT1131395B (it) 1986-06-18
AU5970080A (en) 1981-01-08

Similar Documents

Publication Publication Date Title
SE8004792L (sv) Nya tetra- eller pentapeptider, forfaranden for framstellning av desamma och farmaceutiska kompositioner innehallande desamma
DE3275295D1 (en) Anti-srs-a carboxylic acid derivatives, processes for their production, and pharmaceutical formulation containing them
AU515774B2 (en) Benzopyran derivatives
PT76316A (en) Process for the preparation of esters of substituted pyridino- 3,5-dicarboxylic and/or of pyrano-3,5-dicarboxylic acids having an hypotensive effect and application thereof for the preparation of pharmaceutical compositions having an hypotensive effect
DE3062609D1 (en) Muramyldipeptide derivatives, process for preparing said compounds and pharmaceutical compositions containing said compounds
LU91587I2 (fr) Agomélatine et ses dérivés pharmaceutiquement acceptables (VALDOXAN)
JPS57212157A (en) Collagenase inhibitory compound
SE8004790L (sv) Nya dipeptider, forfarande for framstellning av desamma och farmaceutiska kompositioner innehallande desamma
SE8000205L (sv) Nya heterotricykliska derivat, sett for framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa derivat
SE8107634L (sv) Nya tri-, tetra- och pentapeptider, forfaranden for framstellning av desamma och lekemedel innehallande desamma
ES465340A1 (es) Procedimiento para la obtencion de derivados de amino-azu- car.
SE8006716L (sv) Cytostatiskt verksamma beredningar, nya isocyanursyraderivat och forfarande for deras framstellning
SE8004791L (sv) Nya tripeptider, forfaranden for framstellning av desamma och farmaceutiska kompositioner innehallande desamma
SE7605361L (sv) Sett att framstella nya n-substituerade fenylpiperazinderivat
PT91607A (pt) Process for the preparation of substituted beta-diketones and of pharmaceutical compositions containing them
GB1434323A (en) N-acylated substituted piperazine or homopiperazine derivatives and processes for their preparation
ZA944727B (en) Phosphonic acid compounds processes for preparing them and pharmaceutical compositions containing them
SE7514477L (sv) Forfarande for framstellning och anvendning av nya xantinderivat
SE8206981L (sv) N-(vinblastonyl-23)-derivat av aminosyror, deras framstellning och farmaceutiska kompositioner
RO87991A (ro) Procedeu pentru prepararea unor esteri tiazolidinici substituiti ai unor acizi minerali
ES435361A1 (es) Un metodo para la preparacion de nuevos esteres alcohilicosde aminoacidos.
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
SE7608306L (sv) Nya 5-fluoropyrimidin-4-on-derivat
DE3866292D1 (de) Piperazinylalkylpiperazindion-derivate, ihre verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
GB1552099A (en) Cephalosporin analogues

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8004792-1

Effective date: 19930109

Format of ref document f/p: F